Sporomex Limited

Sporomex Limited is a UK-based research and licensing company specializing in microencapsulation technology derived from plant pollens and spores. The company utilizes a chemical or enzyme-based process to remove genetic material from pollen grains, resulting in non-allergenic, porous, inert, and elastic shells. These microcapsules serve as natural, plant-based delivery vehicles for active substances, offering antioxidant properties and taste-masking capabilities. Their technology is designed for applications across the pharmaceutical, food, beverage, cosmetic, and personal care industries, and can also be used for medical imaging enhancement. The company functions primarily as a collaborative research entity, licensing its patented technology to international partners and providing consultancy for feasibility trials rather than engaging in large-scale manufacturing.

The company was founded in 2002 as a spin-out from the University of Hull and holds multiple international patent families related to the extraction and application of sporopollenin exine shells. By providing an alternative to synthetic plastic beads, Sporomex addresses environmental concerns within the cosmetics and personal care sectors. Its business model focuses on collaborative partnerships, where licensees commission feasibility trials to test the integration of their specific compounds with Sporomex technology. Through these engagements, Sporomex supports product development from the research phase through to licensing agreements, leveraging expertise in bioorganic chemistry and technology transfer to facilitate innovation in delivery systems across various regulated markets.